data_6saa_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6saa _Structure_validation_residue.Date_analyzed 2020-07-17 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 31.1 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.612 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 93.4 mt -80.82 132.8 35.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -80.78 -177.84 6.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -63.87 126.79 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 111.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.23 19.97 24.4 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.369 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.03 131.41 46.94 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.29 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.763 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -64.03 121.53 14.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.017 0.437 . . . . 0.0 112.06 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.78 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.4 p -150.66 -177.75 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.403 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 20.2 m 73.31 11.3 4.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.08 -167.49 29.22 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.941 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.03 151.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.901 3.067 . . . . 0.0 112.707 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 13' ' ' ILE . 12.3 tt -16.56 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 125.036 1.46 . . . . 0.0 113.632 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.55 92.52 3.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.24 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -94.5 104.3 16.26 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.179 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -171.14 99.42 0.41 Allowed Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 40.9 Cg_endo -68.92 125.73 12.96 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.479 0.786 . . . . 0.0 111.099 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.612 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -83.67 150.67 25.72 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 77.53 9.88 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.0 -177.47 43.35 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.68 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -92.74 136.31 33.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 168.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.31 123.78 29.95 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.785 -0.572 . . . . 0.0 110.508 177.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t -159.29 141.58 13.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.75 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 45.67 47.81 11.53 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.188 0.995 . . . . 0.0 113.559 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 77.6 mtt180 58.98 33.23 22.91 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.086 0.47 . . . . 0.0 110.925 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -145.02 139.95 27.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.492 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.5 m -86.23 120.82 28.0 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.673 -171.077 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 23.3 p . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.624 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 94.3 mt -84.7 138.73 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -88.63 -177.75 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.756 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.87 124.25 20.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.389 0.614 . . . . 0.0 111.524 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.04 12.96 28.36 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.691 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.61 121.81 42.23 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.977 0.388 . . . . 0.0 110.465 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -57.75 121.56 10.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 112.32 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.904 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 9.1 p -149.29 177.05 10.0 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.549 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 15.5 m 71.78 12.0 6.27 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.607 0.718 . . . . 0.0 110.125 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.25 -167.03 28.96 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.502 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.84 157.55 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.384 2.722 . . . . 0.0 112.699 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 tt -17.19 103.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 124.982 1.427 . . . . 0.0 113.776 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -138.9 86.39 2.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.652 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.09 101.34 13.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.199 -1.401 . . . . 0.0 108.991 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 mt -174.15 101.99 0.29 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 126.165 1.786 . . . . 0.0 106.465 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 37.8 Cg_endo -69.46 132.26 23.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.692 0.926 . . . . 0.0 111.367 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.624 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -84.64 151.43 24.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 78.46 9.89 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 167.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.52 -177.89 43.44 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.589 -171.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -92.05 141.84 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 168.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.562 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -92.01 111.68 23.32 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.875 -0.515 . . . . 0.0 110.386 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -149.17 135.19 19.01 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.752 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 55.86 53.52 9.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.904 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 38.3 ptt180 43.75 44.9 5.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.527 0.731 . . . . 0.0 111.68 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 ptpp? -160.35 138.74 10.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 31.7 m -77.34 125.9 30.07 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.254 1.292 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.501 -173.21 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.3 p . . . . . 0 CA--C 1.517 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.619 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.2 mt -86.59 138.9 31.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.24 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -83.57 178.95 7.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -68.53 119.29 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.19 17.16 11.88 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.774 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.45 168.08 9.97 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -92.11 124.58 36.3 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.66 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.9 t -143.42 161.71 37.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t 69.56 11.38 7.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.523 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.22 -166.3 42.19 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.597 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' ILE . 22.7 Cg_endo -61.62 165.4 13.65 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.395 2.063 . . . . 0.0 110.882 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' PRO . 4.0 tt -16.47 99.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 124.646 1.216 . . . . 0.0 113.671 -167.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 9' ' ' CYS . 2.7 tm0? -144.32 86.16 1.82 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.172 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -94.17 103.13 15.18 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 118.611 -1.235 . . . . 0.0 108.862 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.9 mt -173.96 101.7 0.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 126.23 1.812 . . . . 0.0 106.666 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.6 131.94 22.52 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 120.679 0.919 . . . . 0.0 111.073 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.619 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 9.1 m -83.38 153.36 24.59 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.364 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.2 m -84.44 78.45 9.82 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.47 -177.78 43.47 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.672 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -92.71 125.95 37.56 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -72.08 99.57 2.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.044 0.45 . . . . 0.0 110.148 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -140.01 125.31 18.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 63.66 38.99 9.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.909 0.483 . . . . 0.0 111.971 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 35.5 mtt180 61.63 27.41 16.86 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.826 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.774 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 54.8 mttm -136.63 137.76 40.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.333 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.0 m -83.86 118.44 23.97 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.042 0.839 . . . . 0.0 111.326 -168.905 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.922 0.392 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.588 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.5 mt -86.37 138.32 31.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.218 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.61 179.8 5.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.761 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -58.91 120.81 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.439 0.638 . . . . 0.0 110.978 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.26 21.86 12.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.189 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.92 129.39 46.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.4 119.81 12.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.499 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.844 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 15.3 p -145.61 -168.96 3.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.157 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m 69.1 13.49 8.7 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.573 0.701 . . . . 0.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.22 -165.97 28.84 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.699 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.49 155.41 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.186 2.59 . . . . 0.0 112.097 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 tt -20.02 100.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 124.859 1.35 . . . . 0.0 113.602 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' OE1' ' HB2' ' A' ' 9' ' ' CYS . 2.7 tm0? -129.42 91.35 3.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.967 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.25 102.74 15.02 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.772 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.9 mt -171.48 98.58 0.4 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.27 125.63 12.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 120.532 0.822 . . . . 0.0 110.956 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.588 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.8 m -83.15 151.28 25.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.99 77.97 9.83 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.55 43.09 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.283 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -97.56 131.34 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.46 102.66 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.042 0.448 . . . . 0.0 110.314 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 16.3 t -125.17 116.82 22.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.929 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 6.6 ptp180 40.73 56.68 2.8 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.185 0.994 . . . . 0.0 113.274 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.844 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 44.9 mtm180 69.38 25.64 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -143.25 131.82 22.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 169.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 55.6 m -75.87 127.46 33.04 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.044 -173.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.019 0.438 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.601 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.0 mt -78.97 135.36 36.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.726 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -179.92 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.695 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.76 122.52 16.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.344 0.593 . . . . 0.0 111.346 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.77 16.23 16.23 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.581 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.03 132.29 45.48 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.229 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.26 118.91 10.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.349 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.827 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.7 p -147.31 -176.59 5.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.934 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t 73.75 1.09 3.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.364 0.602 . . . . 0.0 110.611 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.79 -166.02 40.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.498 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.35 161.57 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.543 2.162 . . . . 0.0 111.156 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 tt -16.81 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 124.698 1.249 . . . . 0.0 114.22 -165.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -131.13 92.0 3.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.235 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -93.03 102.68 15.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.109 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -172.63 99.83 0.35 Allowed Pre-proline 0 N--CA 1.466 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 106.511 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.52 128.03 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 120.792 0.994 . . . . 0.0 111.463 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.601 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.9 m -84.28 150.12 25.63 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 77.98 9.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.57 -178.61 43.1 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.712 -173.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -89.29 135.93 33.31 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.21 105.77 17.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.683 0.278 . . . . 0.0 110.408 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -135.09 133.21 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.085 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.479 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 12.1 ptp180 40.87 52.55 3.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.361 1.064 . . . . 0.0 113.628 174.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 8.4 mpt_? 60.91 33.19 19.96 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 2.6 mptp? -143.49 137.38 28.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.66 168.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 28.7 m -82.09 126.78 32.41 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.843 -174.238 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.066 0.46 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.593 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 95.8 mt -87.08 138.53 31.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.546 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.72 179.34 5.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -60.68 120.17 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.99 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.73 20.0 11.34 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.432 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -101.02 141.47 33.87 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.828 0.314 . . . . 0.0 110.156 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -75.51 117.47 17.33 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.706 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.854 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 12.4 p -142.85 -172.07 3.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.189 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 14.9 m 67.45 16.18 9.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.63 -168.31 28.68 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.624 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.58 158.59 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.027 2.485 . . . . 0.0 112.01 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 tt -16.49 94.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 124.913 1.383 . . . . 0.0 113.946 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -127.47 90.04 3.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.888 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -93.44 101.78 14.0 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.61 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.5 mt -172.76 99.12 0.35 Allowed Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 106.397 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.57 129.15 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 120.709 0.939 . . . . 0.0 111.412 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.593 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.2 m -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.2 m -87.36 78.35 8.73 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.22 -178.75 43.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.313 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.436 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 85.2 m -90.31 128.82 36.53 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 169.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -75.7 99.71 4.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.383 0.611 . . . . 0.0 109.829 176.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.9 m -126.34 116.16 20.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.604 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 14.1 ptp180 40.54 57.2 2.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.485 1.114 . . . . 0.0 113.758 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.854 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 17.7 mtp180 71.37 21.69 4.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -139.21 136.16 34.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.031 0.443 . . . . 0.0 110.802 170.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 35.2 m -81.76 122.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 21' ' ' THR . 65.5 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.194 -169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 20.4 p . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.957 0.408 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.606 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 98.2 mt -80.0 141.25 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.34 177.22 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.668 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -66.52 114.07 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.506 . . . . 0.0 110.744 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.18 19.24 7.71 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.967 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.65 149.66 23.54 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -83.16 118.33 23.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.551 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 17.7 p -144.34 -178.76 6.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.705 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 69.9 m 65.39 12.51 8.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.22 0.533 . . . . 0.0 110.823 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.09 -166.77 34.3 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -42.05 139.93 2.37 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.233 2.622 . . . . 0.0 111.762 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 tt -16.33 96.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 125.022 1.451 . . . . 0.0 113.758 -168.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -122.11 96.4 5.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.885 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -94.9 103.85 15.73 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.653 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.7 mt -171.89 99.68 0.38 Allowed Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.211 1.804 . . . . 0.0 106.399 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 35.5 Cg_endo -67.59 127.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 120.836 1.024 . . . . 0.0 111.261 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.606 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.49 150.63 25.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.4 m -84.42 78.91 9.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 167.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.93 -178.07 43.6 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.095 -173.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -94.85 129.55 41.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.3 m -77.88 114.68 16.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.013 0.435 . . . . 0.0 110.665 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.468 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.4 t -133.43 114.53 13.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG3' ' C ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 39.29 59.16 1.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 36.7 mtt180 74.41 21.26 2.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 1.8 mptp? -139.93 137.64 34.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 171.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 26.5 m -84.65 126.23 33.18 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 168.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.526 -174.688 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.178 0.513 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.61 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.1 mt -91.22 136.75 32.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.357 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -87.45 -178.33 6.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.651 0.262 . . . . 0.0 110.738 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.71 122.58 16.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 111.07 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.87 16.68 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.112 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.8 141.46 33.64 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.668 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -73.2 119.37 17.35 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.858 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.805 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 13.8 p -147.57 179.31 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.541 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.641 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 21.0 m 73.24 8.34 5.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.12 0.568 . . . . 0.0 110.868 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.1 -167.91 43.82 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.664 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.6 149.27 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.27 2.647 . . . . 0.0 112.096 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 tt -16.49 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 124.979 1.424 . . . . 0.0 113.809 -169.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -124.35 93.13 3.82 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.282 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -93.44 104.47 16.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.036 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mt -171.32 98.96 0.4 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.58 127.84 15.33 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.51 0.806 . . . . 0.0 111.181 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.61 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.98 152.49 24.42 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -84.54 78.02 9.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.78 -178.05 43.52 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.525 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.6 m -96.52 130.33 43.72 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.641 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.1 m -77.19 118.83 20.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.744 0.306 . . . . 0.0 110.787 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 t -148.38 129.33 14.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 18.6 ptp180 43.51 48.62 6.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.425 1.09 . . . . 0.0 113.514 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.805 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.6 mtt180 68.59 25.77 6.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 2.3 mptp? -140.8 140.47 34.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.466 0.651 . . . . 0.0 111.117 171.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 29.3 m -84.5 127.33 33.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.246 0.88 0 O-C-N 123.62 0.575 . . . . 0.0 111.106 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 26.9 p . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.592 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 92.0 mt -85.32 133.3 34.15 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.224 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -91.52 -177.62 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.593 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.04 114.88 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 111.533 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.26 18.9 8.78 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.499 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.79 147.46 26.04 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -80.87 122.41 27.18 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.512 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.835 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -149.4 -172.12 4.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.54 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 12.4 m 70.13 13.57 7.74 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.403 0.621 . . . . 0.0 111.018 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.09 -169.27 29.47 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.842 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.5 157.45 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.203 2.602 . . . . 0.0 112.352 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 tt -15.94 92.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.808 1.318 . . . . 0.0 113.967 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -127.15 93.28 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.352 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -94.25 105.07 17.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.491 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mt -170.58 98.2 0.44 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 41.9 Cg_endo -69.54 126.57 13.62 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.491 0.794 . . . . 0.0 110.987 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.592 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -82.93 145.2 29.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.45 78.18 9.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 169.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.68 -177.59 43.09 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.216 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -96.76 132.33 42.57 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.54 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -80.93 116.04 20.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.093 -0.38 . . . . 0.0 110.783 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -147.47 120.21 8.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.305 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 83.9 mtt180 59.66 46.81 11.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 170.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 19.4 mtp180 63.32 28.19 15.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.15 0.432 . . . . 0.0 110.946 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 12.2 mtpt -141.51 133.52 27.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.498 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.8 m -85.98 122.17 29.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.478 -174.059 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.597 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 90.3 mt -85.89 139.3 31.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.164 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -88.29 179.64 6.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.13 122.99 16.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.333 0.587 . . . . 0.0 111.114 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.87 18.63 19.7 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.511 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.86 132.24 46.36 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.606 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -63.53 122.84 17.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.133 -0.354 . . . . 0.0 111.655 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.884 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -152.19 -170.6 3.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.69 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 9.2 m 71.08 11.74 6.93 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.945 0.402 . . . . 0.0 111.27 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.82 -168.97 32.35 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.729 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.53 164.7 5.3 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.993 2.462 . . . . 0.0 111.78 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 tt -14.0 89.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.423 1.106 . . . . 0.0 113.854 -165.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -125.08 87.09 2.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.038 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.28 103.35 15.37 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.377 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -172.09 98.4 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.81 127.89 15.2 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 120.971 1.114 . . . . 0.0 111.253 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.597 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -84.0 150.0 25.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -84.46 78.31 9.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 166.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.17 -179.21 43.15 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.175 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -95.21 126.08 40.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -74.92 120.04 19.91 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.952 -0.467 . . . . 0.0 110.888 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 t -150.09 131.13 14.36 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.461 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 55.25 42.44 30.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.3 mtm180 59.75 35.05 22.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.059 0.457 . . . . 0.0 111.801 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 20.8 ptmt -152.87 129.08 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.783 0.802 . . . . 0.0 111.213 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 29.3 m -74.77 128.72 36.24 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.663 -173.105 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.924 0.392 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 31.1 p -175.61 149.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.35 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.612 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 93.4 mt -80.82 132.8 35.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -80.78 -177.84 6.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -63.87 126.79 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 111.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.23 19.97 24.4 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.369 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.03 131.41 46.94 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.29 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.763 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -64.03 121.53 14.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.017 0.437 . . . . 0.0 112.06 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.78 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.4 p -150.66 -177.75 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.403 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 20.2 m 73.31 11.3 4.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.08 -167.49 29.22 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.941 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.03 151.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.901 3.067 . . . . 0.0 112.707 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 13' ' ' ILE . 12.3 tt -16.56 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 125.036 1.46 . . . . 0.0 113.632 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.55 92.52 3.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.24 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -94.5 104.3 16.26 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.179 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -171.14 99.42 0.41 Allowed Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 40.9 Cg_endo -68.92 125.73 12.96 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.479 0.786 . . . . 0.0 111.099 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.612 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -83.67 150.67 25.72 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 77.53 9.88 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.0 -177.47 43.35 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.68 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -92.74 136.31 33.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 168.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.31 123.78 29.95 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.785 -0.572 . . . . 0.0 110.508 177.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t -159.29 141.58 13.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.75 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 45.67 47.81 11.53 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.188 0.995 . . . . 0.0 113.559 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 77.6 mtt180 58.98 33.23 22.91 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.086 0.47 . . . . 0.0 110.925 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -145.02 139.95 27.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.492 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.5 m -86.23 120.82 28.0 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.673 -171.077 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.656 0.265 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 23.3 p -156.69 148.34 22.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 0.0 111.054 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.624 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 94.3 mt -84.7 138.73 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -88.63 -177.75 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.756 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.87 124.25 20.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.389 0.614 . . . . 0.0 111.524 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.04 12.96 28.36 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.691 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.61 121.81 42.23 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.977 0.388 . . . . 0.0 110.465 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -57.75 121.56 10.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 112.32 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.904 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 9.1 p -149.29 177.05 10.0 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.549 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 15.5 m 71.78 12.0 6.27 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.607 0.718 . . . . 0.0 110.125 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.25 -167.03 28.96 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.502 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.84 157.55 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.384 2.722 . . . . 0.0 112.699 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 tt -17.19 103.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 124.982 1.427 . . . . 0.0 113.776 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -138.9 86.39 2.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.652 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.09 101.34 13.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.199 -1.401 . . . . 0.0 108.991 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 mt -174.15 101.99 0.29 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 126.165 1.786 . . . . 0.0 106.465 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 37.8 Cg_endo -69.46 132.26 23.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.692 0.926 . . . . 0.0 111.367 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.624 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -84.64 151.43 24.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 78.46 9.89 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 167.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.52 -177.89 43.44 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.589 -171.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -92.05 141.84 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 168.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.562 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -92.01 111.68 23.32 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.875 -0.515 . . . . 0.0 110.386 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -149.17 135.19 19.01 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.752 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 55.86 53.52 9.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.904 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 38.3 ptt180 43.75 44.9 5.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.527 0.731 . . . . 0.0 111.68 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 ptpp? -160.35 138.74 10.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 31.7 m -77.34 125.9 30.07 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.254 1.292 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.501 -173.21 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.756 0.313 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.3 p -166.16 156.92 12.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.057 0.456 . . . . 0.0 110.432 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.619 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.2 mt -86.59 138.9 31.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.24 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -83.57 178.95 7.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -68.53 119.29 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.19 17.16 11.88 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.774 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.45 168.08 9.97 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -92.11 124.58 36.3 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.66 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.9 t -143.42 161.71 37.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t 69.56 11.38 7.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.523 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.22 -166.3 42.19 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.597 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' ILE . 22.7 Cg_endo -61.62 165.4 13.65 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.395 2.063 . . . . 0.0 110.882 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' PRO . 4.0 tt -16.47 99.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 124.646 1.216 . . . . 0.0 113.671 -167.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 9' ' ' CYS . 2.7 tm0? -144.32 86.16 1.82 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.172 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -94.17 103.13 15.18 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 118.611 -1.235 . . . . 0.0 108.862 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.9 mt -173.96 101.7 0.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 126.23 1.812 . . . . 0.0 106.666 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.6 131.94 22.52 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 120.679 0.919 . . . . 0.0 111.073 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.619 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 9.1 m -83.38 153.36 24.59 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.364 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.2 m -84.44 78.45 9.82 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.47 -177.78 43.47 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.672 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -92.71 125.95 37.56 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -72.08 99.57 2.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.044 0.45 . . . . 0.0 110.148 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -140.01 125.31 18.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 63.66 38.99 9.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.909 0.483 . . . . 0.0 111.971 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 35.5 mtt180 61.63 27.41 16.86 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.826 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.774 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 54.8 mttm -136.63 137.76 40.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.333 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.0 m -83.86 118.44 23.97 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.042 0.839 . . . . 0.0 111.326 -168.905 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.998 0.428 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p -125.35 159.41 31.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.035 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.588 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.5 mt -86.37 138.32 31.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.218 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.61 179.8 5.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.761 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -58.91 120.81 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.439 0.638 . . . . 0.0 110.978 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.26 21.86 12.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.189 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.92 129.39 46.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.4 119.81 12.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.499 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.844 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 15.3 p -145.61 -168.96 3.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.157 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m 69.1 13.49 8.7 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.573 0.701 . . . . 0.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.22 -165.97 28.84 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.699 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.49 155.41 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.186 2.59 . . . . 0.0 112.097 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 tt -20.02 100.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 124.859 1.35 . . . . 0.0 113.602 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' OE1' ' HB2' ' A' ' 9' ' ' CYS . 2.7 tm0? -129.42 91.35 3.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.967 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.25 102.74 15.02 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.772 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.9 mt -171.48 98.58 0.4 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.27 125.63 12.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 120.532 0.822 . . . . 0.0 110.956 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.588 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.8 m -83.15 151.28 25.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.99 77.97 9.83 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.55 43.09 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.283 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -97.56 131.34 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.46 102.66 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.042 0.448 . . . . 0.0 110.314 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 16.3 t -125.17 116.82 22.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.929 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 6.6 ptp180 40.73 56.68 2.8 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.185 0.994 . . . . 0.0 113.274 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.844 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 44.9 mtm180 69.38 25.64 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -143.25 131.82 22.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 169.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 55.6 m -75.87 127.46 33.04 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.044 -173.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p -128.8 149.4 50.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.326 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.601 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.0 mt -78.97 135.36 36.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.726 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -179.92 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.695 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.76 122.52 16.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.344 0.593 . . . . 0.0 111.346 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.77 16.23 16.23 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.581 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.03 132.29 45.48 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.229 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.26 118.91 10.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.349 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.827 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.7 p -147.31 -176.59 5.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.934 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t 73.75 1.09 3.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.364 0.602 . . . . 0.0 110.611 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.79 -166.02 40.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.498 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.35 161.57 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.543 2.162 . . . . 0.0 111.156 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 tt -16.81 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 124.698 1.249 . . . . 0.0 114.22 -165.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -131.13 92.0 3.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.235 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -93.03 102.68 15.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.109 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -172.63 99.83 0.35 Allowed Pre-proline 0 N--CA 1.466 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 106.511 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.52 128.03 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 120.792 0.994 . . . . 0.0 111.463 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.601 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.9 m -84.28 150.12 25.63 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 77.98 9.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.57 -178.61 43.1 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.712 -173.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -89.29 135.93 33.31 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.21 105.77 17.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.683 0.278 . . . . 0.0 110.408 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -135.09 133.21 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.085 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.479 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 12.1 ptp180 40.87 52.55 3.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.361 1.064 . . . . 0.0 113.628 174.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 8.4 mpt_? 60.91 33.19 19.96 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 2.6 mptp? -143.49 137.38 28.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.66 168.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 28.7 m -82.09 126.78 32.41 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.843 -174.238 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.8 p -115.65 163.01 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.066 0.46 . . . . 0.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.593 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 95.8 mt -87.08 138.53 31.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.546 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.72 179.34 5.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -60.68 120.17 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.99 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.73 20.0 11.34 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.432 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -101.02 141.47 33.87 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.828 0.314 . . . . 0.0 110.156 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -75.51 117.47 17.33 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.706 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.854 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 12.4 p -142.85 -172.07 3.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.189 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 14.9 m 67.45 16.18 9.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.63 -168.31 28.68 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.624 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.58 158.59 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.027 2.485 . . . . 0.0 112.01 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 tt -16.49 94.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 124.913 1.383 . . . . 0.0 113.946 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -127.47 90.04 3.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.888 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -93.44 101.78 14.0 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.61 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.5 mt -172.76 99.12 0.35 Allowed Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 106.397 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.57 129.15 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 120.709 0.939 . . . . 0.0 111.412 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.593 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.2 m -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.2 m -87.36 78.35 8.73 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.22 -178.75 43.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.313 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.436 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 85.2 m -90.31 128.82 36.53 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 169.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -75.7 99.71 4.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.383 0.611 . . . . 0.0 109.829 176.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.9 m -126.34 116.16 20.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.604 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 14.1 ptp180 40.54 57.2 2.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.485 1.114 . . . . 0.0 113.758 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.854 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 17.7 mtp180 71.37 21.69 4.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -139.21 136.16 34.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.031 0.443 . . . . 0.0 110.802 170.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 35.2 m -81.76 122.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 21' ' ' THR . 65.5 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.194 -169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 20.4 p -148.3 150.37 33.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 0.0 110.734 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.606 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 98.2 mt -80.0 141.25 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.34 177.22 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.668 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -66.52 114.07 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.506 . . . . 0.0 110.744 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.18 19.24 7.71 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.967 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.65 149.66 23.54 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -83.16 118.33 23.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.551 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 17.7 p -144.34 -178.76 6.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.705 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 69.9 m 65.39 12.51 8.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.22 0.533 . . . . 0.0 110.823 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.09 -166.77 34.3 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -42.05 139.93 2.37 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.233 2.622 . . . . 0.0 111.762 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 tt -16.33 96.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 125.022 1.451 . . . . 0.0 113.758 -168.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -122.11 96.4 5.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.885 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -94.9 103.85 15.73 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.653 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.7 mt -171.89 99.68 0.38 Allowed Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.211 1.804 . . . . 0.0 106.399 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 35.5 Cg_endo -67.59 127.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 120.836 1.024 . . . . 0.0 111.261 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.606 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.49 150.63 25.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.4 m -84.42 78.91 9.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 167.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.93 -178.07 43.6 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.095 -173.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -94.85 129.55 41.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.3 m -77.88 114.68 16.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.013 0.435 . . . . 0.0 110.665 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.468 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.4 t -133.43 114.53 13.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG3' ' C ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 39.29 59.16 1.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 36.7 mtt180 74.41 21.26 2.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 1.8 mptp? -139.93 137.64 34.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 171.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 26.5 m -84.65 126.23 33.18 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 168.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.526 -174.688 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 p -141.48 168.65 19.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.891 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.61 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.1 mt -91.22 136.75 32.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.357 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -87.45 -178.33 6.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.651 0.262 . . . . 0.0 110.738 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.71 122.58 16.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 111.07 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.87 16.68 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.112 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.8 141.46 33.64 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.668 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -73.2 119.37 17.35 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.858 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.805 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 13.8 p -147.57 179.31 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.541 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.641 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 21.0 m 73.24 8.34 5.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.12 0.568 . . . . 0.0 110.868 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.1 -167.91 43.82 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.664 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.6 149.27 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.27 2.647 . . . . 0.0 112.096 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 tt -16.49 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 124.979 1.424 . . . . 0.0 113.809 -169.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -124.35 93.13 3.82 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.282 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -93.44 104.47 16.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.036 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mt -171.32 98.96 0.4 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.58 127.84 15.33 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.51 0.806 . . . . 0.0 111.181 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.61 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.98 152.49 24.42 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -84.54 78.02 9.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.78 -178.05 43.52 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.525 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.6 m -96.52 130.33 43.72 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.641 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.1 m -77.19 118.83 20.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.744 0.306 . . . . 0.0 110.787 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 t -148.38 129.33 14.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 18.6 ptp180 43.51 48.62 6.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.425 1.09 . . . . 0.0 113.514 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.805 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.6 mtt180 68.59 25.77 6.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 2.3 mptp? -140.8 140.47 34.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.466 0.651 . . . . 0.0 111.117 171.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 29.3 m -84.5 127.33 33.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.246 0.88 0 O-C-N 123.62 0.575 . . . . 0.0 111.106 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.775 0.322 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 26.9 p -150.15 151.24 32.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.592 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 92.0 mt -85.32 133.3 34.15 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.224 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -91.52 -177.62 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.593 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.04 114.88 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 111.533 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.26 18.9 8.78 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.499 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.79 147.46 26.04 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -80.87 122.41 27.18 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.512 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.835 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -149.4 -172.12 4.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.54 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 12.4 m 70.13 13.57 7.74 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.403 0.621 . . . . 0.0 111.018 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.09 -169.27 29.47 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.842 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.5 157.45 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.203 2.602 . . . . 0.0 112.352 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 tt -15.94 92.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.808 1.318 . . . . 0.0 113.967 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -127.15 93.28 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.352 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -94.25 105.07 17.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.491 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mt -170.58 98.2 0.44 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 41.9 Cg_endo -69.54 126.57 13.62 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.491 0.794 . . . . 0.0 110.987 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.592 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -82.93 145.2 29.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.45 78.18 9.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 169.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.68 -177.59 43.09 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.216 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -96.76 132.33 42.57 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.54 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -80.93 116.04 20.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.093 -0.38 . . . . 0.0 110.783 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -147.47 120.21 8.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.305 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 83.9 mtt180 59.66 46.81 11.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 170.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 19.4 mtp180 63.32 28.19 15.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.15 0.432 . . . . 0.0 110.946 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 12.2 mtpt -141.51 133.52 27.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.498 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.8 m -85.98 122.17 29.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.478 -174.059 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.53 155.89 39.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.131 0.491 . . . . 0.0 110.356 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.597 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 90.3 mt -85.89 139.3 31.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.164 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -88.29 179.64 6.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.13 122.99 16.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.333 0.587 . . . . 0.0 111.114 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.87 18.63 19.7 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.511 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.86 132.24 46.36 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.606 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -63.53 122.84 17.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.133 -0.354 . . . . 0.0 111.655 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.884 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -152.19 -170.6 3.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.69 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 9.2 m 71.08 11.74 6.93 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.945 0.402 . . . . 0.0 111.27 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.82 -168.97 32.35 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.729 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.53 164.7 5.3 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.993 2.462 . . . . 0.0 111.78 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 tt -14.0 89.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.423 1.106 . . . . 0.0 113.854 -165.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -125.08 87.09 2.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.038 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.28 103.35 15.37 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.377 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -172.09 98.4 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.81 127.89 15.2 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 120.971 1.114 . . . . 0.0 111.253 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.597 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -84.0 150.0 25.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -84.46 78.31 9.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 166.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.17 -179.21 43.15 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.175 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -95.21 126.08 40.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -74.92 120.04 19.91 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.952 -0.467 . . . . 0.0 110.888 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 t -150.09 131.13 14.36 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.461 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 55.25 42.44 30.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.3 mtm180 59.75 35.05 22.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.059 0.457 . . . . 0.0 111.801 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 20.8 ptmt -152.87 129.08 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.783 0.802 . . . . 0.0 111.213 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 29.3 m -74.77 128.72 36.24 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.663 -173.105 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 31.1 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 93.4 mt -80.82 132.8 35.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -80.78 -177.84 6.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -63.87 126.79 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 111.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.23 19.97 24.4 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.369 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . -101.03 131.41 46.94 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.29 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -64.03 121.53 14.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.017 0.437 . . . . 0.0 112.06 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.782 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.4 p -150.66 -177.75 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.403 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 20.2 m 73.31 11.3 4.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.08 -167.49 29.22 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.941 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.03 151.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.901 3.067 . . . . 0.0 112.707 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ILE . 12.3 tt -16.56 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 125.036 1.46 . . . . 0.0 113.632 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.55 92.52 3.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.24 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -94.5 104.3 16.26 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.179 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -171.14 99.42 0.41 Allowed Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 40.9 Cg_endo -68.92 125.73 12.96 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.479 0.786 . . . . 0.0 111.099 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.678 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -83.67 150.67 25.72 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 77.53 9.88 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.0 -177.47 43.35 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.68 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -92.74 136.31 33.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 168.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.524 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.31 123.78 29.95 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.785 -0.572 . . . . 0.0 110.508 177.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t -159.29 141.58 13.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.75 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 45.67 47.81 11.53 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.188 0.995 . . . . 0.0 113.559 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.782 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 77.6 mtt180 58.98 33.23 22.91 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.086 0.47 . . . . 0.0 110.925 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -145.02 139.95 27.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.492 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.5 m -86.23 120.82 28.0 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.673 -171.077 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 23.3 p . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.705 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 94.3 mt -84.7 138.73 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -88.63 -177.75 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.756 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.87 124.25 20.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.389 0.614 . . . . 0.0 111.524 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.04 12.96 28.36 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.691 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.61 121.81 42.23 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.977 0.388 . . . . 0.0 110.465 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -57.75 121.56 10.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 112.32 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.908 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 9.1 p -149.29 177.05 10.0 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.549 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.559 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 15.5 m 71.78 12.0 6.27 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.607 0.718 . . . . 0.0 110.125 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.25 -167.03 28.96 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.502 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.84 157.55 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.384 2.722 . . . . 0.0 112.699 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 tt -17.19 103.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 124.982 1.427 . . . . 0.0 113.776 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -138.9 86.39 2.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.652 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.09 101.34 13.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.199 -1.401 . . . . 0.0 108.991 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 mt -174.15 101.99 0.29 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 126.165 1.786 . . . . 0.0 106.465 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 37.8 Cg_endo -69.46 132.26 23.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.692 0.926 . . . . 0.0 111.367 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.705 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -84.64 151.43 24.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 78.46 9.89 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 167.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.52 -177.89 43.44 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.589 -171.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -92.05 141.84 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 168.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.559 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -92.01 111.68 23.32 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.875 -0.515 . . . . 0.0 110.386 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -149.17 135.19 19.01 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.752 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 55.86 53.52 9.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.908 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 38.3 ptt180 43.75 44.9 5.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.527 0.731 . . . . 0.0 111.68 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 ptpp? -160.35 138.74 10.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 31.7 m -77.34 125.9 30.07 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.254 1.292 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.501 -173.21 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.3 p . . . . . 0 CA--C 1.517 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.698 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.2 mt -86.59 138.9 31.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.24 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -83.57 178.95 7.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -68.53 119.29 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.19 17.16 11.88 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.45 168.08 9.97 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -92.11 124.58 36.3 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.66 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.9 t -143.42 161.71 37.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t 69.56 11.38 7.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.523 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.22 -166.3 42.19 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.597 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' ILE . 22.7 Cg_endo -61.62 165.4 13.65 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.395 2.063 . . . . 0.0 110.882 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.0 tt -16.47 99.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 124.646 1.216 . . . . 0.0 113.671 -167.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -144.32 86.16 1.82 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.172 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -94.17 103.13 15.18 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 118.611 -1.235 . . . . 0.0 108.862 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.9 mt -173.96 101.7 0.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 126.23 1.812 . . . . 0.0 106.666 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.6 131.94 22.52 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 120.679 0.919 . . . . 0.0 111.073 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.698 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 9.1 m -83.38 153.36 24.59 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.364 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.2 m -84.44 78.45 9.82 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.47 -177.78 43.47 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.672 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -92.71 125.95 37.56 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -72.08 99.57 2.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.044 0.45 . . . . 0.0 110.148 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -140.01 125.31 18.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 63.66 38.99 9.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.909 0.483 . . . . 0.0 111.971 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 35.5 mtt180 61.63 27.41 16.86 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.826 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 54.8 mttm -136.63 137.76 40.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.333 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.0 m -83.86 118.44 23.97 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.042 0.839 . . . . 0.0 111.326 -168.905 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.922 0.392 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.663 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.5 mt -86.37 138.32 31.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.218 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.61 179.8 5.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.761 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -58.91 120.81 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.439 0.638 . . . . 0.0 110.978 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.26 21.86 12.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.189 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.92 129.39 46.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.4 119.81 12.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.499 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.855 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 15.3 p -145.61 -168.96 3.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.157 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m 69.1 13.49 8.7 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.573 0.701 . . . . 0.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.22 -165.97 28.84 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.699 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.49 155.41 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.186 2.59 . . . . 0.0 112.097 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 tt -20.02 100.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 124.859 1.35 . . . . 0.0 113.602 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 9' ' ' CYS . 2.7 tm0? -129.42 91.35 3.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.967 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.25 102.74 15.02 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.772 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.9 mt -171.48 98.58 0.4 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.27 125.63 12.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 120.532 0.822 . . . . 0.0 110.956 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.8 m -83.15 151.28 25.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.99 77.97 9.83 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.55 43.09 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.283 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -97.56 131.34 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.46 102.66 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.042 0.448 . . . . 0.0 110.314 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 16.3 t -125.17 116.82 22.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.929 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 6.6 ptp180 40.73 56.68 2.8 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.185 0.994 . . . . 0.0 113.274 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.855 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 44.9 mtm180 69.38 25.64 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HD3' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -143.25 131.82 22.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 169.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 55.6 m -75.87 127.46 33.04 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.044 -173.888 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.019 0.438 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.0 mt -78.97 135.36 36.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.726 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -179.92 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.695 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.76 122.52 16.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.344 0.593 . . . . 0.0 111.346 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.77 16.23 16.23 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.581 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.03 132.29 45.48 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.229 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.26 118.91 10.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.349 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.843 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.7 p -147.31 -176.59 5.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.934 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t 73.75 1.09 3.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.364 0.602 . . . . 0.0 110.611 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.79 -166.02 40.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.498 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.35 161.57 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.543 2.162 . . . . 0.0 111.156 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 tt -16.81 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 124.698 1.249 . . . . 0.0 114.22 -165.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -131.13 92.0 3.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.235 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -93.03 102.68 15.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.109 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -172.63 99.83 0.35 Allowed Pre-proline 0 N--CA 1.466 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 106.511 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.52 128.03 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 120.792 0.994 . . . . 0.0 111.463 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.666 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.9 m -84.28 150.12 25.63 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 77.98 9.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.57 -178.61 43.1 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.712 -173.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -89.29 135.93 33.31 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.21 105.77 17.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.683 0.278 . . . . 0.0 110.408 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -135.09 133.21 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.085 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 12.1 ptp180 40.87 52.55 3.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.361 1.064 . . . . 0.0 113.628 174.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.843 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 8.4 mpt_? 60.91 33.19 19.96 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 2.6 mptp? -143.49 137.38 28.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.66 168.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 28.7 m -82.09 126.78 32.41 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.843 -174.238 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.066 0.46 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.668 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 95.8 mt -87.08 138.53 31.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.546 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.72 179.34 5.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -60.68 120.17 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.99 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.73 20.0 11.34 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.432 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -101.02 141.47 33.87 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.828 0.314 . . . . 0.0 110.156 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -75.51 117.47 17.33 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.706 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 12.4 p -142.85 -172.07 3.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.189 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 14.9 m 67.45 16.18 9.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.63 -168.31 28.68 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.624 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.58 158.59 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.027 2.485 . . . . 0.0 112.01 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 tt -16.49 94.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 124.913 1.383 . . . . 0.0 113.946 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -127.47 90.04 3.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.888 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -93.44 101.78 14.0 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.61 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.5 mt -172.76 99.12 0.35 Allowed Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 106.397 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.57 129.15 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 120.709 0.939 . . . . 0.0 111.412 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.668 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.2 m -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.2 m -87.36 78.35 8.73 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.22 -178.75 43.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.313 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.447 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 85.2 m -90.31 128.82 36.53 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 169.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -75.7 99.71 4.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.383 0.611 . . . . 0.0 109.829 176.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.9 m -126.34 116.16 20.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.604 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 14.1 ptp180 40.54 57.2 2.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.485 1.114 . . . . 0.0 113.758 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.869 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 17.7 mtp180 71.37 21.69 4.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -139.21 136.16 34.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.031 0.443 . . . . 0.0 110.802 170.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 35.2 m -81.76 122.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 21' ' ' THR . 65.5 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.194 -169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 20.4 p . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.957 0.408 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 98.2 mt -80.0 141.25 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.34 177.22 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.668 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -66.52 114.07 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.506 . . . . 0.0 110.744 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.18 19.24 7.71 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.967 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.65 149.66 23.54 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -83.16 118.33 23.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.551 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.823 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 17.7 p -144.34 -178.76 6.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.705 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 69.9 m 65.39 12.51 8.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.22 0.533 . . . . 0.0 110.823 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.09 -166.77 34.3 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -42.05 139.93 2.37 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.233 2.622 . . . . 0.0 111.762 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 tt -16.33 96.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 125.022 1.451 . . . . 0.0 113.758 -168.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -122.11 96.4 5.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.885 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -94.9 103.85 15.73 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.653 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.7 mt -171.89 99.68 0.38 Allowed Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.211 1.804 . . . . 0.0 106.399 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 35.5 Cg_endo -67.59 127.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 120.836 1.024 . . . . 0.0 111.261 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.49 150.63 25.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.4 m -84.42 78.91 9.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 167.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.93 -178.07 43.6 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.095 -173.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -94.85 129.55 41.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.628 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.3 m -77.88 114.68 16.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.013 0.435 . . . . 0.0 110.665 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.4 t -133.43 114.53 13.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HG3' ' C ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 39.29 59.16 1.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.823 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 36.7 mtt180 74.41 21.26 2.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.627 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 1.8 mptp? -139.93 137.64 34.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 171.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 26.5 m -84.65 126.23 33.18 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 168.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.526 -174.688 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.178 0.513 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.693 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.1 mt -91.22 136.75 32.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.357 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -87.45 -178.33 6.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.651 0.262 . . . . 0.0 110.738 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.71 122.58 16.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 111.07 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.87 16.68 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.112 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.8 141.46 33.64 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -73.2 119.37 17.35 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.858 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.816 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 13.8 p -147.57 179.31 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.541 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.65 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 21.0 m 73.24 8.34 5.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.12 0.568 . . . . 0.0 110.868 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.1 -167.91 43.82 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.664 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.6 149.27 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.27 2.647 . . . . 0.0 112.096 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 tt -16.49 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 124.979 1.424 . . . . 0.0 113.809 -169.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -124.35 93.13 3.82 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.282 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -93.44 104.47 16.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.036 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mt -171.32 98.96 0.4 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.58 127.84 15.33 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.51 0.806 . . . . 0.0 111.181 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.98 152.49 24.42 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -84.54 78.02 9.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.78 -178.05 43.52 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.525 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.6 m -96.52 130.33 43.72 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.65 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.1 m -77.19 118.83 20.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.744 0.306 . . . . 0.0 110.787 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 t -148.38 129.33 14.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 18.6 ptp180 43.51 48.62 6.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.425 1.09 . . . . 0.0 113.514 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.6 mtt180 68.59 25.77 6.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 2.3 mptp? -140.8 140.47 34.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.466 0.651 . . . . 0.0 111.117 171.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 29.3 m -84.5 127.33 33.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.246 0.88 0 O-C-N 123.62 0.575 . . . . 0.0 111.106 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 26.9 p . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 92.0 mt -85.32 133.3 34.15 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.224 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -91.52 -177.62 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.593 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.04 114.88 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 111.533 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.26 18.9 8.78 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.499 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.79 147.46 26.04 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -80.87 122.41 27.18 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.512 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -149.4 -172.12 4.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.539 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 12.4 m 70.13 13.57 7.74 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.403 0.621 . . . . 0.0 111.018 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.09 -169.27 29.47 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.842 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.5 157.45 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.203 2.602 . . . . 0.0 112.352 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 tt -15.94 92.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.808 1.318 . . . . 0.0 113.967 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -127.15 93.28 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.352 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -94.25 105.07 17.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.491 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mt -170.58 98.2 0.44 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 41.9 Cg_endo -69.54 126.57 13.62 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.491 0.794 . . . . 0.0 110.987 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -82.93 145.2 29.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.45 78.18 9.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 169.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.68 -177.59 43.09 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.216 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -96.76 132.33 42.57 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -80.93 116.04 20.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.093 -0.38 . . . . 0.0 110.783 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -147.47 120.21 8.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.305 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.518 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 83.9 mtt180 59.66 46.81 11.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 170.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 19.4 mtp180 63.32 28.19 15.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.15 0.432 . . . . 0.0 110.946 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 12.2 mtpt -141.51 133.52 27.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.498 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.8 m -85.98 122.17 29.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.478 -174.059 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.675 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 90.3 mt -85.89 139.3 31.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.164 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -88.29 179.64 6.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.13 122.99 16.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.333 0.587 . . . . 0.0 111.114 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.87 18.63 19.7 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.511 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.86 132.24 46.36 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.606 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -63.53 122.84 17.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.133 -0.354 . . . . 0.0 111.655 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.895 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -152.19 -170.6 3.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.69 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 9.2 m 71.08 11.74 6.93 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.945 0.402 . . . . 0.0 111.27 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.82 -168.97 32.35 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.729 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.53 164.7 5.3 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.993 2.462 . . . . 0.0 111.78 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 tt -14.0 89.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.423 1.106 . . . . 0.0 113.854 -165.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -125.08 87.09 2.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.038 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.28 103.35 15.37 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.377 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -172.09 98.4 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.81 127.89 15.2 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 120.971 1.114 . . . . 0.0 111.253 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -84.0 150.0 25.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -84.46 78.31 9.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 166.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.17 -179.21 43.15 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.175 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -95.21 126.08 40.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -74.92 120.04 19.91 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.952 -0.467 . . . . 0.0 110.888 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 t -150.09 131.13 14.36 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.461 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 55.25 42.44 30.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.895 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.3 mtm180 59.75 35.05 22.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.059 0.457 . . . . 0.0 111.801 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 20.8 ptmt -152.87 129.08 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.783 0.802 . . . . 0.0 111.213 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 29.3 m -74.77 128.72 36.24 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.663 -173.105 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.924 0.392 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 31.1 p -175.61 149.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.35 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 93.4 mt -80.82 132.8 35.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -80.78 -177.84 6.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -63.87 126.79 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 111.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.23 19.97 24.4 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.369 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . -101.03 131.41 46.94 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.29 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -64.03 121.53 14.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.017 0.437 . . . . 0.0 112.06 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.782 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.4 p -150.66 -177.75 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.403 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 20.2 m 73.31 11.3 4.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.08 -167.49 29.22 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.941 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.03 151.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.901 3.067 . . . . 0.0 112.707 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ILE . 12.3 tt -16.56 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 125.036 1.46 . . . . 0.0 113.632 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.55 92.52 3.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.24 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -94.5 104.3 16.26 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.179 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -171.14 99.42 0.41 Allowed Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 40.9 Cg_endo -68.92 125.73 12.96 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.479 0.786 . . . . 0.0 111.099 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -83.67 150.67 25.72 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 77.53 9.88 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.0 -177.47 43.35 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.68 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -92.74 136.31 33.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 168.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.524 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.31 123.78 29.95 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.785 -0.572 . . . . 0.0 110.508 177.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t -159.29 141.58 13.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.75 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 45.67 47.81 11.53 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.188 0.995 . . . . 0.0 113.559 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.782 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 77.6 mtt180 58.98 33.23 22.91 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.086 0.47 . . . . 0.0 110.925 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -145.02 139.95 27.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.492 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.5 m -86.23 120.82 28.0 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.673 -171.077 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.656 0.265 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 23.3 p -156.69 148.34 22.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 0.0 111.054 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.705 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 94.3 mt -84.7 138.73 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -88.63 -177.75 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.756 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.87 124.25 20.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.389 0.614 . . . . 0.0 111.524 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.04 12.96 28.36 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.691 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.61 121.81 42.23 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.977 0.388 . . . . 0.0 110.465 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -57.75 121.56 10.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 112.32 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.908 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 9.1 p -149.29 177.05 10.0 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.549 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.559 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 15.5 m 71.78 12.0 6.27 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.607 0.718 . . . . 0.0 110.125 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.25 -167.03 28.96 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.502 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.84 157.55 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.384 2.722 . . . . 0.0 112.699 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 tt -17.19 103.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 124.982 1.427 . . . . 0.0 113.776 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -138.9 86.39 2.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.652 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.09 101.34 13.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.199 -1.401 . . . . 0.0 108.991 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 mt -174.15 101.99 0.29 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 126.165 1.786 . . . . 0.0 106.465 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 37.8 Cg_endo -69.46 132.26 23.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.692 0.926 . . . . 0.0 111.367 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.705 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -84.64 151.43 24.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 78.46 9.89 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 167.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.52 -177.89 43.44 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.589 -171.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -92.05 141.84 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 168.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.559 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -92.01 111.68 23.32 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.875 -0.515 . . . . 0.0 110.386 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -149.17 135.19 19.01 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.752 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 55.86 53.52 9.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.908 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 38.3 ptt180 43.75 44.9 5.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.527 0.731 . . . . 0.0 111.68 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 ptpp? -160.35 138.74 10.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 31.7 m -77.34 125.9 30.07 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.254 1.292 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.501 -173.21 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.756 0.313 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.3 p -166.16 156.92 12.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.057 0.456 . . . . 0.0 110.432 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.698 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.2 mt -86.59 138.9 31.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.24 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -83.57 178.95 7.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -68.53 119.29 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.19 17.16 11.88 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.45 168.08 9.97 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -92.11 124.58 36.3 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.66 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.9 t -143.42 161.71 37.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t 69.56 11.38 7.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.523 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.22 -166.3 42.19 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.597 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' ILE . 22.7 Cg_endo -61.62 165.4 13.65 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.395 2.063 . . . . 0.0 110.882 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.0 tt -16.47 99.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 124.646 1.216 . . . . 0.0 113.671 -167.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -144.32 86.16 1.82 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.172 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -94.17 103.13 15.18 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 118.611 -1.235 . . . . 0.0 108.862 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.9 mt -173.96 101.7 0.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 126.23 1.812 . . . . 0.0 106.666 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.6 131.94 22.52 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 120.679 0.919 . . . . 0.0 111.073 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.698 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 9.1 m -83.38 153.36 24.59 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.364 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.2 m -84.44 78.45 9.82 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.47 -177.78 43.47 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.672 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -92.71 125.95 37.56 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -72.08 99.57 2.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.044 0.45 . . . . 0.0 110.148 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -140.01 125.31 18.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 63.66 38.99 9.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.909 0.483 . . . . 0.0 111.971 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 35.5 mtt180 61.63 27.41 16.86 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.826 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 54.8 mttm -136.63 137.76 40.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.333 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.0 m -83.86 118.44 23.97 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.042 0.839 . . . . 0.0 111.326 -168.905 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.998 0.428 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p -125.35 159.41 31.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.035 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.663 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.5 mt -86.37 138.32 31.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.218 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.61 179.8 5.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.761 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -58.91 120.81 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.439 0.638 . . . . 0.0 110.978 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.26 21.86 12.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.189 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.92 129.39 46.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.4 119.81 12.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.499 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.855 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 15.3 p -145.61 -168.96 3.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.157 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m 69.1 13.49 8.7 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.573 0.701 . . . . 0.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.22 -165.97 28.84 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.699 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.49 155.41 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.186 2.59 . . . . 0.0 112.097 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 tt -20.02 100.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 124.859 1.35 . . . . 0.0 113.602 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 9' ' ' CYS . 2.7 tm0? -129.42 91.35 3.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.967 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.25 102.74 15.02 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.772 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.9 mt -171.48 98.58 0.4 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.27 125.63 12.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 120.532 0.822 . . . . 0.0 110.956 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.8 m -83.15 151.28 25.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.99 77.97 9.83 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.55 43.09 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.283 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -97.56 131.34 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.46 102.66 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.042 0.448 . . . . 0.0 110.314 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 16.3 t -125.17 116.82 22.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.929 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 6.6 ptp180 40.73 56.68 2.8 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.185 0.994 . . . . 0.0 113.274 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.855 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 44.9 mtm180 69.38 25.64 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HD3' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -143.25 131.82 22.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 169.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 55.6 m -75.87 127.46 33.04 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.044 -173.888 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p -128.8 149.4 50.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.326 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.0 mt -78.97 135.36 36.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.726 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -179.92 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.695 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.76 122.52 16.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.344 0.593 . . . . 0.0 111.346 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.77 16.23 16.23 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.581 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.03 132.29 45.48 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.229 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.26 118.91 10.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.349 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.843 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.7 p -147.31 -176.59 5.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.934 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t 73.75 1.09 3.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.364 0.602 . . . . 0.0 110.611 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.79 -166.02 40.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.498 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.35 161.57 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.543 2.162 . . . . 0.0 111.156 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 tt -16.81 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 124.698 1.249 . . . . 0.0 114.22 -165.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -131.13 92.0 3.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.235 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -93.03 102.68 15.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.109 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -172.63 99.83 0.35 Allowed Pre-proline 0 N--CA 1.466 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 106.511 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.52 128.03 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 120.792 0.994 . . . . 0.0 111.463 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.666 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.9 m -84.28 150.12 25.63 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 77.98 9.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.57 -178.61 43.1 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.712 -173.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -89.29 135.93 33.31 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.21 105.77 17.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.683 0.278 . . . . 0.0 110.408 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -135.09 133.21 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.085 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 12.1 ptp180 40.87 52.55 3.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.361 1.064 . . . . 0.0 113.628 174.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.843 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 8.4 mpt_? 60.91 33.19 19.96 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 2.6 mptp? -143.49 137.38 28.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.66 168.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 28.7 m -82.09 126.78 32.41 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.843 -174.238 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.8 p -115.65 163.01 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.066 0.46 . . . . 0.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.668 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 95.8 mt -87.08 138.53 31.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.546 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.72 179.34 5.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -60.68 120.17 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.99 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.73 20.0 11.34 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.432 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -101.02 141.47 33.87 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.828 0.314 . . . . 0.0 110.156 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -75.51 117.47 17.33 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.706 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 12.4 p -142.85 -172.07 3.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.189 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 14.9 m 67.45 16.18 9.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.63 -168.31 28.68 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.624 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.58 158.59 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.027 2.485 . . . . 0.0 112.01 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 tt -16.49 94.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 124.913 1.383 . . . . 0.0 113.946 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -127.47 90.04 3.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.888 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -93.44 101.78 14.0 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.61 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.5 mt -172.76 99.12 0.35 Allowed Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 106.397 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.57 129.15 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 120.709 0.939 . . . . 0.0 111.412 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.668 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.2 m -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.2 m -87.36 78.35 8.73 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.22 -178.75 43.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.313 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.447 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 85.2 m -90.31 128.82 36.53 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 169.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -75.7 99.71 4.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.383 0.611 . . . . 0.0 109.829 176.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.9 m -126.34 116.16 20.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.604 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 14.1 ptp180 40.54 57.2 2.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.485 1.114 . . . . 0.0 113.758 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.869 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 17.7 mtp180 71.37 21.69 4.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -139.21 136.16 34.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.031 0.443 . . . . 0.0 110.802 170.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 35.2 m -81.76 122.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 21' ' ' THR . 65.5 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.194 -169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 20.4 p -148.3 150.37 33.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 0.0 110.734 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 98.2 mt -80.0 141.25 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.34 177.22 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.668 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -66.52 114.07 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.506 . . . . 0.0 110.744 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.18 19.24 7.71 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.967 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.65 149.66 23.54 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -83.16 118.33 23.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.551 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.823 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 17.7 p -144.34 -178.76 6.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.705 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 69.9 m 65.39 12.51 8.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.22 0.533 . . . . 0.0 110.823 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.09 -166.77 34.3 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -42.05 139.93 2.37 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.233 2.622 . . . . 0.0 111.762 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 tt -16.33 96.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 125.022 1.451 . . . . 0.0 113.758 -168.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -122.11 96.4 5.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.885 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -94.9 103.85 15.73 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.653 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.7 mt -171.89 99.68 0.38 Allowed Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.211 1.804 . . . . 0.0 106.399 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 35.5 Cg_endo -67.59 127.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 120.836 1.024 . . . . 0.0 111.261 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.49 150.63 25.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.4 m -84.42 78.91 9.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 167.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.93 -178.07 43.6 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.095 -173.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -94.85 129.55 41.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.628 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.3 m -77.88 114.68 16.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.013 0.435 . . . . 0.0 110.665 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.4 t -133.43 114.53 13.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HG3' ' C ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 39.29 59.16 1.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.823 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 36.7 mtt180 74.41 21.26 2.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.627 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 1.8 mptp? -139.93 137.64 34.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 171.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 26.5 m -84.65 126.23 33.18 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 168.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.526 -174.688 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 p -141.48 168.65 19.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.891 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.693 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.1 mt -91.22 136.75 32.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.357 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -87.45 -178.33 6.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.651 0.262 . . . . 0.0 110.738 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.71 122.58 16.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 111.07 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.87 16.68 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.112 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.8 141.46 33.64 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -73.2 119.37 17.35 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.858 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.816 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 13.8 p -147.57 179.31 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.541 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.65 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 21.0 m 73.24 8.34 5.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.12 0.568 . . . . 0.0 110.868 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.1 -167.91 43.82 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.664 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.6 149.27 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.27 2.647 . . . . 0.0 112.096 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 tt -16.49 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 124.979 1.424 . . . . 0.0 113.809 -169.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -124.35 93.13 3.82 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.282 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -93.44 104.47 16.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.036 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mt -171.32 98.96 0.4 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.58 127.84 15.33 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.51 0.806 . . . . 0.0 111.181 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.98 152.49 24.42 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -84.54 78.02 9.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.78 -178.05 43.52 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.525 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.6 m -96.52 130.33 43.72 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.65 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.1 m -77.19 118.83 20.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.744 0.306 . . . . 0.0 110.787 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 t -148.38 129.33 14.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 18.6 ptp180 43.51 48.62 6.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.425 1.09 . . . . 0.0 113.514 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.6 mtt180 68.59 25.77 6.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 2.3 mptp? -140.8 140.47 34.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.466 0.651 . . . . 0.0 111.117 171.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 29.3 m -84.5 127.33 33.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.246 0.88 0 O-C-N 123.62 0.575 . . . . 0.0 111.106 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.775 0.322 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 26.9 p -150.15 151.24 32.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 92.0 mt -85.32 133.3 34.15 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.224 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -91.52 -177.62 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.593 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.04 114.88 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 111.533 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.26 18.9 8.78 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.499 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.79 147.46 26.04 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -80.87 122.41 27.18 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.512 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -149.4 -172.12 4.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.539 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 12.4 m 70.13 13.57 7.74 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.403 0.621 . . . . 0.0 111.018 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.09 -169.27 29.47 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.842 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.5 157.45 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.203 2.602 . . . . 0.0 112.352 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 tt -15.94 92.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.808 1.318 . . . . 0.0 113.967 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -127.15 93.28 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.352 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -94.25 105.07 17.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.491 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mt -170.58 98.2 0.44 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 41.9 Cg_endo -69.54 126.57 13.62 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.491 0.794 . . . . 0.0 110.987 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -82.93 145.2 29.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.45 78.18 9.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 169.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.68 -177.59 43.09 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.216 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -96.76 132.33 42.57 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -80.93 116.04 20.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.093 -0.38 . . . . 0.0 110.783 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -147.47 120.21 8.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.305 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.518 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 83.9 mtt180 59.66 46.81 11.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 170.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 19.4 mtp180 63.32 28.19 15.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.15 0.432 . . . . 0.0 110.946 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 12.2 mtpt -141.51 133.52 27.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.498 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.8 m -85.98 122.17 29.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.478 -174.059 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.53 155.89 39.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.131 0.491 . . . . 0.0 110.356 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.675 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 90.3 mt -85.89 139.3 31.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.164 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -88.29 179.64 6.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.13 122.99 16.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.333 0.587 . . . . 0.0 111.114 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.87 18.63 19.7 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.511 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.86 132.24 46.36 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.606 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -63.53 122.84 17.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.133 -0.354 . . . . 0.0 111.655 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.895 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -152.19 -170.6 3.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.69 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 9.2 m 71.08 11.74 6.93 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.945 0.402 . . . . 0.0 111.27 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.82 -168.97 32.35 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.729 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.53 164.7 5.3 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.993 2.462 . . . . 0.0 111.78 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 tt -14.0 89.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.423 1.106 . . . . 0.0 113.854 -165.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -125.08 87.09 2.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.038 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.28 103.35 15.37 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.377 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -172.09 98.4 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.81 127.89 15.2 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 120.971 1.114 . . . . 0.0 111.253 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -84.0 150.0 25.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -84.46 78.31 9.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 166.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.17 -179.21 43.15 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.175 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -95.21 126.08 40.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -74.92 120.04 19.91 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.952 -0.467 . . . . 0.0 110.888 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 t -150.09 131.13 14.36 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.461 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 55.25 42.44 30.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.895 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.3 mtm180 59.75 35.05 22.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.059 0.457 . . . . 0.0 111.801 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 20.8 ptmt -152.87 129.08 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.783 0.802 . . . . 0.0 111.213 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 29.3 m -74.77 128.72 36.24 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.663 -173.105 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 31.1 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 93.4 mt -80.82 132.8 35.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -80.78 -177.84 6.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -63.87 126.79 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 111.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.23 19.97 24.4 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.369 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . -101.03 131.41 46.94 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.29 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -64.03 121.53 14.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.017 0.437 . . . . 0.0 112.06 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.782 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.4 p -150.66 -177.75 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.403 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 20.2 m 73.31 11.3 4.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.08 -167.49 29.22 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.941 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.03 151.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.901 3.067 . . . . 0.0 112.707 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ILE . 12.3 tt -16.56 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 125.036 1.46 . . . . 0.0 113.632 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.55 92.52 3.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.24 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -94.5 104.3 16.26 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.179 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -171.14 99.42 0.41 Allowed Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 40.9 Cg_endo -68.92 125.73 12.96 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.479 0.786 . . . . 0.0 111.099 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.678 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -83.67 150.67 25.72 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 77.53 9.88 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.0 -177.47 43.35 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.68 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -92.74 136.31 33.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 168.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.524 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.31 123.78 29.95 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.785 -0.572 . . . . 0.0 110.508 177.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t -159.29 141.58 13.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.75 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 45.67 47.81 11.53 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.188 0.995 . . . . 0.0 113.559 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.782 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 77.6 mtt180 58.98 33.23 22.91 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.086 0.47 . . . . 0.0 110.925 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -145.02 139.95 27.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.492 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.5 m -86.23 120.82 28.0 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.673 -171.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 23.3 p . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.332 0.587 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.705 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 94.3 mt -84.7 138.73 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -88.63 -177.75 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.756 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.87 124.25 20.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.389 0.614 . . . . 0.0 111.524 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.04 12.96 28.36 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.691 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.61 121.81 42.23 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.977 0.388 . . . . 0.0 110.465 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -57.75 121.56 10.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 112.32 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.908 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 9.1 p -149.29 177.05 10.0 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.549 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.559 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 15.5 m 71.78 12.0 6.27 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.607 0.718 . . . . 0.0 110.125 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.25 -167.03 28.96 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.502 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.84 157.55 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.384 2.722 . . . . 0.0 112.699 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 tt -17.19 103.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 124.982 1.427 . . . . 0.0 113.776 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -138.9 86.39 2.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.652 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.09 101.34 13.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.199 -1.401 . . . . 0.0 108.991 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 mt -174.15 101.99 0.29 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 126.165 1.786 . . . . 0.0 106.465 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 37.8 Cg_endo -69.46 132.26 23.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.692 0.926 . . . . 0.0 111.367 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.705 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -84.64 151.43 24.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 78.46 9.89 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 167.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.52 -177.89 43.44 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.589 -171.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -92.05 141.84 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 168.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.559 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -92.01 111.68 23.32 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.875 -0.515 . . . . 0.0 110.386 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -149.17 135.19 19.01 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.752 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 55.86 53.52 9.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.908 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 38.3 ptt180 43.75 44.9 5.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.527 0.731 . . . . 0.0 111.68 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 ptpp? -160.35 138.74 10.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 31.7 m -77.34 125.9 30.07 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.254 1.292 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.501 -173.21 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.3 p . . . . . 0 CA--C 1.517 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.698 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.2 mt -86.59 138.9 31.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.24 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -83.57 178.95 7.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -68.53 119.29 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.19 17.16 11.88 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.45 168.08 9.97 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -92.11 124.58 36.3 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.66 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.9 t -143.42 161.71 37.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t 69.56 11.38 7.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.523 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.22 -166.3 42.19 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.597 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' ILE . 22.7 Cg_endo -61.62 165.4 13.65 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.395 2.063 . . . . 0.0 110.882 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.0 tt -16.47 99.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 124.646 1.216 . . . . 0.0 113.671 -167.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -144.32 86.16 1.82 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.172 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -94.17 103.13 15.18 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 118.611 -1.235 . . . . 0.0 108.862 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.9 mt -173.96 101.7 0.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 126.23 1.812 . . . . 0.0 106.666 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.6 131.94 22.52 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 120.679 0.919 . . . . 0.0 111.073 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.698 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 9.1 m -83.38 153.36 24.59 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.364 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.2 m -84.44 78.45 9.82 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.47 -177.78 43.47 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.672 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -92.71 125.95 37.56 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -72.08 99.57 2.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.044 0.45 . . . . 0.0 110.148 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -140.01 125.31 18.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 63.66 38.99 9.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.909 0.483 . . . . 0.0 111.971 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 35.5 mtt180 61.63 27.41 16.86 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.826 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 54.8 mttm -136.63 137.76 40.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.333 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.0 m -83.86 118.44 23.97 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.042 0.839 . . . . 0.0 111.326 -168.905 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.922 0.392 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.663 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.5 mt -86.37 138.32 31.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.218 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.61 179.8 5.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.761 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -58.91 120.81 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.439 0.638 . . . . 0.0 110.978 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.26 21.86 12.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.189 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.92 129.39 46.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.4 119.81 12.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.499 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.855 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 15.3 p -145.61 -168.96 3.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.157 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m 69.1 13.49 8.7 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.573 0.701 . . . . 0.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.22 -165.97 28.84 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.699 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.49 155.41 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.186 2.59 . . . . 0.0 112.097 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 tt -20.02 100.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 124.859 1.35 . . . . 0.0 113.602 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 9' ' ' CYS . 2.7 tm0? -129.42 91.35 3.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.967 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.25 102.74 15.02 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.772 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.9 mt -171.48 98.58 0.4 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.27 125.63 12.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 120.532 0.822 . . . . 0.0 110.956 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.8 m -83.15 151.28 25.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.99 77.97 9.83 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.55 43.09 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.283 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -97.56 131.34 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.46 102.66 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.042 0.448 . . . . 0.0 110.314 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 16.3 t -125.17 116.82 22.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.929 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 6.6 ptp180 40.73 56.68 2.8 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.185 0.994 . . . . 0.0 113.274 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.855 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 44.9 mtm180 69.38 25.64 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HD3' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -143.25 131.82 22.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 169.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 55.6 m -75.87 127.46 33.04 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.044 -173.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.019 0.438 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.0 mt -78.97 135.36 36.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.726 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -179.92 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.695 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.76 122.52 16.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.344 0.593 . . . . 0.0 111.346 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.77 16.23 16.23 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.581 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.03 132.29 45.48 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.229 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.26 118.91 10.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.349 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.843 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.7 p -147.31 -176.59 5.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.934 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t 73.75 1.09 3.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.364 0.602 . . . . 0.0 110.611 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.79 -166.02 40.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.498 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.35 161.57 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.543 2.162 . . . . 0.0 111.156 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 tt -16.81 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 124.698 1.249 . . . . 0.0 114.22 -165.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -131.13 92.0 3.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.235 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -93.03 102.68 15.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.109 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -172.63 99.83 0.35 Allowed Pre-proline 0 N--CA 1.466 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 106.511 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.52 128.03 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 120.792 0.994 . . . . 0.0 111.463 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.666 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.9 m -84.28 150.12 25.63 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 77.98 9.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.57 -178.61 43.1 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.712 -173.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -89.29 135.93 33.31 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.21 105.77 17.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.683 0.278 . . . . 0.0 110.408 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -135.09 133.21 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.085 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 12.1 ptp180 40.87 52.55 3.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.361 1.064 . . . . 0.0 113.628 174.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.843 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 8.4 mpt_? 60.91 33.19 19.96 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 2.6 mptp? -143.49 137.38 28.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.66 168.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 28.7 m -82.09 126.78 32.41 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.843 -174.238 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.066 0.46 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.668 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 95.8 mt -87.08 138.53 31.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.546 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.72 179.34 5.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -60.68 120.17 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.99 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.73 20.0 11.34 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.432 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -101.02 141.47 33.87 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.828 0.314 . . . . 0.0 110.156 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -75.51 117.47 17.33 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.706 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 12.4 p -142.85 -172.07 3.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.189 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 14.9 m 67.45 16.18 9.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.63 -168.31 28.68 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.624 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.58 158.59 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.027 2.485 . . . . 0.0 112.01 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 tt -16.49 94.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 124.913 1.383 . . . . 0.0 113.946 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -127.47 90.04 3.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.888 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -93.44 101.78 14.0 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.61 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.5 mt -172.76 99.12 0.35 Allowed Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 106.397 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.57 129.15 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 120.709 0.939 . . . . 0.0 111.412 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.668 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.2 m -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.2 m -87.36 78.35 8.73 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.22 -178.75 43.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.313 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.447 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 85.2 m -90.31 128.82 36.53 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 169.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -75.7 99.71 4.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.383 0.611 . . . . 0.0 109.829 176.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.9 m -126.34 116.16 20.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.604 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 14.1 ptp180 40.54 57.2 2.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.485 1.114 . . . . 0.0 113.758 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.869 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 17.7 mtp180 71.37 21.69 4.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -139.21 136.16 34.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.031 0.443 . . . . 0.0 110.802 170.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 35.2 m -81.76 122.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 21' ' ' THR . 65.5 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.194 -169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 20.4 p . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.957 0.408 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 98.2 mt -80.0 141.25 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.34 177.22 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.668 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -66.52 114.07 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.506 . . . . 0.0 110.744 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.18 19.24 7.71 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.967 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.65 149.66 23.54 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -83.16 118.33 23.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.551 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.823 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 17.7 p -144.34 -178.76 6.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.705 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 69.9 m 65.39 12.51 8.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.22 0.533 . . . . 0.0 110.823 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.09 -166.77 34.3 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -42.05 139.93 2.37 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.233 2.622 . . . . 0.0 111.762 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 tt -16.33 96.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 125.022 1.451 . . . . 0.0 113.758 -168.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -122.11 96.4 5.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.885 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -94.9 103.85 15.73 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.653 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.7 mt -171.89 99.68 0.38 Allowed Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.211 1.804 . . . . 0.0 106.399 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 35.5 Cg_endo -67.59 127.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 120.836 1.024 . . . . 0.0 111.261 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.49 150.63 25.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.4 m -84.42 78.91 9.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 167.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.93 -178.07 43.6 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.095 -173.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -94.85 129.55 41.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.628 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.3 m -77.88 114.68 16.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.013 0.435 . . . . 0.0 110.665 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.4 t -133.43 114.53 13.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HG3' ' C ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 39.29 59.16 1.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.823 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 36.7 mtt180 74.41 21.26 2.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.627 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 1.8 mptp? -139.93 137.64 34.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 171.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 26.5 m -84.65 126.23 33.18 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 168.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.526 -174.688 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.178 0.513 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.693 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.1 mt -91.22 136.75 32.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.357 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -87.45 -178.33 6.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.651 0.262 . . . . 0.0 110.738 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.71 122.58 16.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 111.07 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.87 16.68 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.112 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.8 141.46 33.64 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -73.2 119.37 17.35 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.858 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.816 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 13.8 p -147.57 179.31 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.541 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.65 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 21.0 m 73.24 8.34 5.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.12 0.568 . . . . 0.0 110.868 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.1 -167.91 43.82 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.664 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.6 149.27 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.27 2.647 . . . . 0.0 112.096 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 tt -16.49 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 124.979 1.424 . . . . 0.0 113.809 -169.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -124.35 93.13 3.82 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.282 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -93.44 104.47 16.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.036 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mt -171.32 98.96 0.4 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.58 127.84 15.33 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.51 0.806 . . . . 0.0 111.181 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.98 152.49 24.42 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -84.54 78.02 9.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.78 -178.05 43.52 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.525 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.6 m -96.52 130.33 43.72 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.65 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.1 m -77.19 118.83 20.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.744 0.306 . . . . 0.0 110.787 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 t -148.38 129.33 14.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 18.6 ptp180 43.51 48.62 6.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.425 1.09 . . . . 0.0 113.514 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.6 mtt180 68.59 25.77 6.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 2.3 mptp? -140.8 140.47 34.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.466 0.651 . . . . 0.0 111.117 171.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 29.3 m -84.5 127.33 33.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.246 0.88 0 O-C-N 123.62 0.575 . . . . 0.0 111.106 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 26.9 p . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 92.0 mt -85.32 133.3 34.15 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.224 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -91.52 -177.62 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.593 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.04 114.88 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 111.533 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.26 18.9 8.78 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.499 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.79 147.46 26.04 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -80.87 122.41 27.18 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.512 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -149.4 -172.12 4.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.539 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 12.4 m 70.13 13.57 7.74 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.403 0.621 . . . . 0.0 111.018 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.09 -169.27 29.47 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.842 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.5 157.45 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.203 2.602 . . . . 0.0 112.352 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 tt -15.94 92.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.808 1.318 . . . . 0.0 113.967 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -127.15 93.28 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.352 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -94.25 105.07 17.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.491 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mt -170.58 98.2 0.44 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 41.9 Cg_endo -69.54 126.57 13.62 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.491 0.794 . . . . 0.0 110.987 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -82.93 145.2 29.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.45 78.18 9.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 169.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.68 -177.59 43.09 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.216 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -96.76 132.33 42.57 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -80.93 116.04 20.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.093 -0.38 . . . . 0.0 110.783 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -147.47 120.21 8.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.305 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.518 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 83.9 mtt180 59.66 46.81 11.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 170.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 19.4 mtp180 63.32 28.19 15.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.15 0.432 . . . . 0.0 110.946 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 12.2 mtpt -141.51 133.52 27.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.498 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.8 m -85.98 122.17 29.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.478 -174.059 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.675 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 90.3 mt -85.89 139.3 31.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.164 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -88.29 179.64 6.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.13 122.99 16.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.333 0.587 . . . . 0.0 111.114 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.87 18.63 19.7 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.511 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.86 132.24 46.36 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.606 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -63.53 122.84 17.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.133 -0.354 . . . . 0.0 111.655 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.895 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -152.19 -170.6 3.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.69 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 9.2 m 71.08 11.74 6.93 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.945 0.402 . . . . 0.0 111.27 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.82 -168.97 32.35 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.729 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.53 164.7 5.3 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.993 2.462 . . . . 0.0 111.78 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 tt -14.0 89.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.423 1.106 . . . . 0.0 113.854 -165.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -125.08 87.09 2.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.038 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.28 103.35 15.37 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.377 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -172.09 98.4 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.81 127.89 15.2 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 120.971 1.114 . . . . 0.0 111.253 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -84.0 150.0 25.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -84.46 78.31 9.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 166.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.17 -179.21 43.15 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.175 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -95.21 126.08 40.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -74.92 120.04 19.91 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.952 -0.467 . . . . 0.0 110.888 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 t -150.09 131.13 14.36 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.461 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 55.25 42.44 30.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.895 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.3 mtm180 59.75 35.05 22.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.059 0.457 . . . . 0.0 111.801 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 20.8 ptmt -152.87 129.08 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.783 0.802 . . . . 0.0 111.213 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 29.3 m -74.77 128.72 36.24 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.663 -173.105 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.924 0.392 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 31.1 p -175.61 149.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.35 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 93.4 mt -80.82 132.8 35.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -80.78 -177.84 6.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -63.87 126.79 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 111.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.23 19.97 24.4 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.369 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 27' ' ' CYS . . . -101.03 131.41 46.94 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.29 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -64.03 121.53 14.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.017 0.437 . . . . 0.0 112.06 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.782 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.4 p -150.66 -177.75 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.403 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 20.2 m 73.31 11.3 4.98 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.08 -167.49 29.22 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.941 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.03 151.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.901 3.067 . . . . 0.0 112.707 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ILE . 12.3 tt -16.56 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 125.036 1.46 . . . . 0.0 113.632 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.55 92.52 3.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.24 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -94.5 104.3 16.26 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.179 168.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -171.14 99.42 0.41 Allowed Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 40.9 Cg_endo -68.92 125.73 12.96 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.479 0.786 . . . . 0.0 111.099 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.678 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -83.67 150.67 25.72 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 77.53 9.88 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.0 -177.47 43.35 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.68 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -92.74 136.31 33.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 168.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.524 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.31 123.78 29.95 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.785 -0.572 . . . . 0.0 110.508 177.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t -159.29 141.58 13.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.75 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 45.67 47.81 11.53 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.188 0.995 . . . . 0.0 113.559 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.782 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 77.6 mtt180 58.98 33.23 22.91 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.086 0.47 . . . . 0.0 110.925 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -145.02 139.95 27.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.492 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.5 m -86.23 120.82 28.0 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.673 -171.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.656 0.265 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 23.3 p -156.69 148.34 22.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 0.0 111.054 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.705 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 94.3 mt -84.7 138.73 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -88.63 -177.75 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.756 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.87 124.25 20.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.389 0.614 . . . . 0.0 111.524 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.04 12.96 28.36 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.691 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.61 121.81 42.23 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.977 0.388 . . . . 0.0 110.465 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -57.75 121.56 10.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 112.32 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.908 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 9.1 p -149.29 177.05 10.0 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.549 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.559 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 15.5 m 71.78 12.0 6.27 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.607 0.718 . . . . 0.0 110.125 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.25 -167.03 28.96 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.502 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.84 157.55 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.384 2.722 . . . . 0.0 112.699 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 tt -17.19 103.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 124.982 1.427 . . . . 0.0 113.776 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -138.9 86.39 2.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.652 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.09 101.34 13.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.199 -1.401 . . . . 0.0 108.991 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 mt -174.15 101.99 0.29 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 126.165 1.786 . . . . 0.0 106.465 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 37.8 Cg_endo -69.46 132.26 23.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.692 0.926 . . . . 0.0 111.367 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.705 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.6 m -84.64 151.43 24.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 78.46 9.89 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 167.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.52 -177.89 43.44 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.589 -171.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -92.05 141.84 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 168.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.559 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -92.01 111.68 23.32 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.875 -0.515 . . . . 0.0 110.386 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -149.17 135.19 19.01 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.752 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 55.86 53.52 9.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.908 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 38.3 ptt180 43.75 44.9 5.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.527 0.731 . . . . 0.0 111.68 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 ptpp? -160.35 138.74 10.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 31.7 m -77.34 125.9 30.07 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.254 1.292 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.501 -173.21 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.756 0.313 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.3 p -166.16 156.92 12.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.057 0.456 . . . . 0.0 110.432 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.698 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.2 mt -86.59 138.9 31.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.24 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -83.57 178.95 7.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -68.53 119.29 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.175 0.512 . . . . 0.0 110.775 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.19 17.16 11.88 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.45 168.08 9.97 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -92.11 124.58 36.3 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.66 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.9 t -143.42 161.71 37.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t 69.56 11.38 7.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.523 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.22 -166.3 42.19 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.597 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' ILE . 22.7 Cg_endo -61.62 165.4 13.65 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.395 2.063 . . . . 0.0 110.882 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.0 tt -16.47 99.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 124.646 1.216 . . . . 0.0 113.671 -167.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -144.32 86.16 1.82 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.172 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -94.17 103.13 15.18 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 118.611 -1.235 . . . . 0.0 108.862 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.9 mt -173.96 101.7 0.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 126.23 1.812 . . . . 0.0 106.666 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.6 131.94 22.52 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 120.679 0.919 . . . . 0.0 111.073 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.698 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 9.1 m -83.38 153.36 24.59 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.364 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.2 m -84.44 78.45 9.82 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.47 -177.78 43.47 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.672 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -92.71 125.95 37.56 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -72.08 99.57 2.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.044 0.45 . . . . 0.0 110.148 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -140.01 125.31 18.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.834 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 63.66 38.99 9.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.909 0.483 . . . . 0.0 111.971 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 35.5 mtt180 61.63 27.41 16.86 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.826 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 54.8 mttm -136.63 137.76 40.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.333 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.0 m -83.86 118.44 23.97 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.042 0.839 . . . . 0.0 111.326 -168.905 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.998 0.428 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p -125.35 159.41 31.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.035 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.663 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 97.5 mt -86.37 138.32 31.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.218 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.61 179.8 5.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.761 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -58.91 120.81 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.439 0.638 . . . . 0.0 110.978 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.26 21.86 12.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.189 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.92 129.39 46.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.4 119.81 12.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.499 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.855 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 15.3 p -145.61 -168.96 3.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.157 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m 69.1 13.49 8.7 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.573 0.701 . . . . 0.0 110.617 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.22 -165.97 28.84 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.699 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.49 155.41 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.186 2.59 . . . . 0.0 112.097 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 tt -20.02 100.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 124.859 1.35 . . . . 0.0 113.602 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 9' ' ' CYS . 2.7 tm0? -129.42 91.35 3.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.967 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.25 102.74 15.02 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.772 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.9 mt -171.48 98.58 0.4 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.27 125.63 12.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 120.532 0.822 . . . . 0.0 110.956 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.8 m -83.15 151.28 25.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.99 77.97 9.83 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.55 43.09 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.283 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -97.56 131.34 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.46 102.66 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.042 0.448 . . . . 0.0 110.314 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 16.3 t -125.17 116.82 22.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.929 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 6.6 ptp180 40.73 56.68 2.8 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.185 0.994 . . . . 0.0 113.274 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.855 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 44.9 mtm180 69.38 25.64 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HD3' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -143.25 131.82 22.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 0.0 110.671 169.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 55.6 m -75.87 127.46 33.04 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.044 -173.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p -128.8 149.4 50.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.326 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.0 mt -78.97 135.36 36.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.726 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -179.92 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.695 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -62.76 122.52 16.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.344 0.593 . . . . 0.0 111.346 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.77 16.23 16.23 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.581 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.03 132.29 45.48 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.229 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -66.26 118.91 10.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.349 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.843 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 11.7 p -147.31 -176.59 5.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.934 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t 73.75 1.09 3.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.364 0.602 . . . . 0.0 110.611 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.79 -166.02 40.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.498 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.35 161.57 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.543 2.162 . . . . 0.0 111.156 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 tt -16.81 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 124.698 1.249 . . . . 0.0 114.22 -165.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -131.13 92.0 3.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.235 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -93.03 102.68 15.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.109 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -172.63 99.83 0.35 Allowed Pre-proline 0 N--CA 1.466 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 106.511 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.52 128.03 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 120.792 0.994 . . . . 0.0 111.463 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.666 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 3.9 m -84.28 150.12 25.63 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 77.98 9.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.57 -178.61 43.1 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.712 -173.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -89.29 135.93 33.31 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.21 105.77 17.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.683 0.278 . . . . 0.0 110.408 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -135.09 133.21 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.085 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 12.1 ptp180 40.87 52.55 3.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.361 1.064 . . . . 0.0 113.628 174.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.843 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 8.4 mpt_? 60.91 33.19 19.96 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 2.6 mptp? -143.49 137.38 28.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.66 168.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 28.7 m -82.09 126.78 32.41 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.843 -174.238 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.8 p -115.65 163.01 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.066 0.46 . . . . 0.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.668 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 95.8 mt -87.08 138.53 31.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.546 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.72 179.34 5.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -60.68 120.17 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.99 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.73 20.0 11.34 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.432 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -101.02 141.47 33.87 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.828 0.314 . . . . 0.0 110.156 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -75.51 117.47 17.33 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.706 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 12.4 p -142.85 -172.07 3.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.189 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 14.9 m 67.45 16.18 9.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.63 -168.31 28.68 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.624 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.58 158.59 1.76 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.027 2.485 . . . . 0.0 112.01 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 tt -16.49 94.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 124.913 1.383 . . . . 0.0 113.946 -169.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -127.47 90.04 3.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.888 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -93.44 101.78 14.0 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.61 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.5 mt -172.76 99.12 0.35 Allowed Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 106.397 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.57 129.15 16.27 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 120.709 0.939 . . . . 0.0 111.412 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.668 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.2 m -83.99 152.82 24.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.2 m -87.36 78.35 8.73 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.22 -178.75 43.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.313 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.447 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 85.2 m -90.31 128.82 36.53 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 169.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -75.7 99.71 4.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.383 0.611 . . . . 0.0 109.829 176.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.9 m -126.34 116.16 20.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.604 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 14.1 ptp180 40.54 57.2 2.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.485 1.114 . . . . 0.0 113.758 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.869 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 17.7 mtp180 71.37 21.69 4.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -139.21 136.16 34.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.031 0.443 . . . . 0.0 110.802 170.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 35.2 m -81.76 122.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 21' ' ' THR . 65.5 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.194 -169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 20.4 p -148.3 150.37 33.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 0.0 110.734 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 98.2 mt -80.0 141.25 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.34 177.22 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.668 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -66.52 114.07 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.506 . . . . 0.0 110.744 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.18 19.24 7.71 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.967 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.65 149.66 23.54 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -83.16 118.33 23.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.551 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.823 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 17.7 p -144.34 -178.76 6.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.705 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 69.9 m 65.39 12.51 8.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.22 0.533 . . . . 0.0 110.823 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.09 -166.77 34.3 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -42.05 139.93 2.37 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.233 2.622 . . . . 0.0 111.762 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 tt -16.33 96.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 125.022 1.451 . . . . 0.0 113.758 -168.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -122.11 96.4 5.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.885 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -94.9 103.85 15.73 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.653 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.7 mt -171.89 99.68 0.38 Allowed Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.211 1.804 . . . . 0.0 106.399 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 35.5 Cg_endo -67.59 127.82 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 120.836 1.024 . . . . 0.0 111.261 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.49 150.63 25.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.4 m -84.42 78.91 9.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 167.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.93 -178.07 43.6 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.095 -173.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -94.85 129.55 41.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.628 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.3 m -77.88 114.68 16.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.013 0.435 . . . . 0.0 110.665 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.46 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.4 t -133.43 114.53 13.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HG3' ' C ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 39.29 59.16 1.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.823 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 36.7 mtt180 74.41 21.26 2.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.627 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 1.8 mptp? -139.93 137.64 34.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 171.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 26.5 m -84.65 126.23 33.18 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 168.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.526 -174.688 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 p -141.48 168.65 19.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.891 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.693 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 96.1 mt -91.22 136.75 32.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.357 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -87.45 -178.33 6.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.651 0.262 . . . . 0.0 110.738 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.71 122.58 16.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 111.07 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.87 16.68 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.112 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.8 141.46 33.64 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -73.2 119.37 17.35 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.858 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.816 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 13.8 p -147.57 179.31 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.541 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.65 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 21.0 m 73.24 8.34 5.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.12 0.568 . . . . 0.0 110.868 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.1 -167.91 43.82 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.664 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.6 149.27 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.27 2.647 . . . . 0.0 112.096 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 tt -16.49 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 124.979 1.424 . . . . 0.0 113.809 -169.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -124.35 93.13 3.82 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.282 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -93.44 104.47 16.61 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.036 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mt -171.32 98.96 0.4 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.58 127.84 15.33 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.51 0.806 . . . . 0.0 111.181 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 5.7 m -83.98 152.49 24.42 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -84.54 78.02 9.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.78 -178.05 43.52 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.525 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.6 m -96.52 130.33 43.72 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.65 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.1 m -77.19 118.83 20.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.744 0.306 . . . . 0.0 110.787 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 t -148.38 129.33 14.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 18.6 ptp180 43.51 48.62 6.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.425 1.09 . . . . 0.0 113.514 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.6 mtt180 68.59 25.77 6.53 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 2.3 mptp? -140.8 140.47 34.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.466 0.651 . . . . 0.0 111.117 171.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 29.3 m -84.5 127.33 33.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.246 0.88 0 O-C-N 123.62 0.575 . . . . 0.0 111.106 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.775 0.322 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 26.9 p -150.15 151.24 32.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.126 0.488 . . . . 0.0 110.341 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 92.0 mt -85.32 133.3 34.15 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.224 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -91.52 -177.62 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.593 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.04 114.88 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 111.533 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.26 18.9 8.78 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.499 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.79 147.46 26.04 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -80.87 122.41 27.18 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.512 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -149.4 -172.12 4.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.539 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 12.4 m 70.13 13.57 7.74 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.403 0.621 . . . . 0.0 111.018 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -100.09 -169.27 29.47 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.842 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.5 157.45 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.203 2.602 . . . . 0.0 112.352 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 tt -15.94 92.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.808 1.318 . . . . 0.0 113.967 -168.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -127.15 93.28 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.352 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -94.25 105.07 17.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.491 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mt -170.58 98.2 0.44 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 41.9 Cg_endo -69.54 126.57 13.62 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.491 0.794 . . . . 0.0 110.987 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.67 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -82.93 145.2 29.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.45 78.18 9.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 169.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.68 -177.59 43.09 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.216 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -96.76 132.33 42.57 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -80.93 116.04 20.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.093 -0.38 . . . . 0.0 110.783 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -147.47 120.21 8.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.305 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.518 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 83.9 mtt180 59.66 46.81 11.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 170.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 19.4 mtp180 63.32 28.19 15.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.15 0.432 . . . . 0.0 110.946 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 12.2 mtpt -141.51 133.52 27.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.498 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 43.8 m -85.98 122.17 29.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.478 -174.059 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.53 155.89 39.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.131 0.491 . . . . 0.0 110.356 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.675 ' H ' ' HA ' ' A' ' 18' ' ' CYS . 90.3 mt -85.89 139.3 31.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.164 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -88.29 179.64 6.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' CYS . . . -61.13 122.99 16.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.333 0.587 . . . . 0.0 111.114 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.87 18.63 19.7 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.511 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' LYS . . . -100.86 132.24 46.36 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.606 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' A' ' 25' ' ' ARG . . . -63.53 122.84 17.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.133 -0.354 . . . . 0.0 111.655 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.895 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 14.3 p -152.19 -170.6 3.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.69 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 22' ' ' CYS . 9.2 m 71.08 11.74 6.93 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.945 0.402 . . . . 0.0 111.27 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.82 -168.97 32.35 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.729 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.53 164.7 5.3 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.993 2.462 . . . . 0.0 111.78 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 tt -14.0 89.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.423 1.106 . . . . 0.0 113.854 -165.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -125.08 87.09 2.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.038 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.28 103.35 15.37 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.377 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -172.09 98.4 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.81 127.89 15.2 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 120.971 1.114 . . . . 0.0 111.253 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 4.0 m -84.0 150.0 25.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -84.46 78.31 9.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 166.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.17 -179.21 43.15 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.175 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -95.21 126.08 40.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -74.92 120.04 19.91 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.952 -0.467 . . . . 0.0 110.888 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 t -150.09 131.13 14.36 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.461 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 55.25 42.44 30.43 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.895 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 43.3 mtm180 59.75 35.05 22.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.059 0.457 . . . . 0.0 111.801 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 20.8 ptmt -152.87 129.08 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.783 0.802 . . . . 0.0 111.213 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 29.3 m -74.77 128.72 36.24 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.663 -173.105 . . . . . . . . 0 0 . 1 stop_ save_